Log in to save to my catalogue

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ab211f33f6d046b6a2a60204977efd04

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

About this item

Full title

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

Publisher

England: BMJ Publishing Group Ltd, Royal College of Psychiatrists and British Psychological Society

Journal title

BMJ mental health, 2024-04, Vol.27 (1), p.e300876

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd, Royal College of Psychiatrists and British Psychological Society

More information

Scope and Contents

Contents

BackgroundUse of psychostimulants and relative drugs has increased worldwide in treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents and adults. Recent studies suggest a potential association between use of psychostimulants and psychotic symptoms. The risk may not be the same between different psychostimulants.ObjectiveTo ass...

Alternative Titles

Full title

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ab211f33f6d046b6a2a60204977efd04

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ab211f33f6d046b6a2a60204977efd04

Other Identifiers

ISSN

2755-9734

E-ISSN

2755-9734

DOI

10.1136/bmjment-2023-300876

How to access this item